Macquarie Group
RMD icon

Macquarie Group’s ResMed RMD Stock Holding History

Macquarie Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-117,564
Closed -$5.99M – 1545
2015
Q3 		$5.99M Sell
117,564
-123,620
-51% -$6.65M 0.01% 672
2015
Q2 		$14M Buy
+241,184
New +$15.2M 0.03% 448
2014
Q4 		– Sell
-1,085,207
Closed -$53.5M – 1609
2014
Q3 		$53.5M Buy
+1,085,207
New +$55.3M 0.11% 168
2014
Q1 		– Sell
-8,190
Closed -$386K – 1581
2013
Q4 		$386K Buy
8,190
+4,328
+112% +$219K ﹤0.01% 1307
2013
Q3 		$204K Buy
+3,862
New +$187K ﹤0.01% 1415

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Macquarie Group's RMD Position: Q2 2026 in Review

Macquarie Group reduced its ResMed (RMD) stake by 27% in Q2 2026, selling an estimated $5.03M and leaving 65,294 shares worth $12.7M. The position accounts for 0.06% of the portfolio, ranked #244.

Macquarie Group first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $106M in Q3 2014. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Macquarie Group held 65,294 shares of ResMed worth $12.7M as of Q2 2026.
  • Macquarie Group sold 24,271 ResMed shares in Q2 2026, an estimated $5.03M.
  • ResMed made up 0.06% of Macquarie Group's portfolio in Q2 2026, its #244 holding.
  • Macquarie Group first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • Macquarie Group's ResMed position peaked at $106M in Q3 2014.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.